InvestorsHub Logo
icon url

Money $hot

06/19/18 11:35 AM

#22605 RE: x1power #22604

IMO, the accuracy needs to be in the 90+ percentile. I'm basing my opinion on the Nanose device that was played/trumped out by management @ Breathtec. The Nanose device had already circled the globe in clinical trials with a reported accuracy rate of 86 percent. Nonetheless, it has yet to find it's way to commercialization.

See 59 Second Video @ CNN

www.cnn.com/2017/11/07/health/na-nose-disease-smell-technology/index.html

The Nanose device was the closet thing to a real world breath analyzer @ Breathtec. Then the rug got pulled out from under common shareholders. The Nanose device was a catalyst used by management to sell cheap Private Placement shares for a clinical setup to conduct clinical trial of Nanose.

In the end...no trial and those PP shares helped to burn the house down at Breathtec. So, when folks complain about my complaining about seeing a device with my own two eyes, they obviously only know half the story. Walk a mile in a Breathtec shareholders shoes!

/////AMG